不同培养基条件下三七根总皂苷与人肠道菌群的体外相互作用
Interaction between Panax notoginseng Root Saponins and Human Gut Microbiota under Different Culture Conditions in Vitro
DOI: 10.12677/br.2026.154025, PDF,    科研立项经费支持
作者: 段方言*#:云南师范大学云南特色生物资源高值化利用教育部工程研究中心,云南 昆明;云南师范大学生命科学学院,云南 昆明;西南联合研究生院,云南 昆明;毛钰婷*:云南师范大学生命科学学院,云南 昆明
关键词: 厌氧培养肠道细菌群落三七皂苷多样性分析培养基Anaerobic Cultivation Gut Bacterial Community Panax notoginseng Saponins Diversity Analysis Culture Medium
摘要: 三七根总皂苷(Panax notoginseng root saponins, PNS)作为三七的主要活性成分,口服后会与肠道菌群发生相互作用,但目前关于不同营养条件下二者互作的认识尚不充分。本研究采用BHI、GAM及GMM培养基对人源粪便菌群进行体外厌氧培养,并分别设立添加PNS的实验组(BHIP, GAMP, GMMP)。通过高效液相色谱定量分析不同培养基条件下5种高含量皂苷的相对代谢率,并用16S rRNA测序解析菌群结构变化。结果显示:BHIP组对皂苷R1、Rb1和Rd的平均相对代谢率 > 73%;GAMP组特异性高效代谢Rb1,代谢率 > 84%;而GMMP组仅代谢R1和Re,且代谢率 < 25%。BHI、GAM与GMM三组所培养的菌群结构存在显著差异;与各自对照组相比,BHIP与GAMP组的菌群α多样性(Shannon指数)显著降低(P < 0.01),群落结构发生显著重构(P < 0.001),而GMMP组则无显著变化。在菌群组成上,BHIP组显著富集了LachnoclostridiumParasutterellaBifidobacterium;GAMP组显著富集了BifidobacteriumEscherichia-Shigella;GMMP组则主要富集了RoseburiaAnaerostipes。综上,PNS与肠道菌群的互作效应在不同培养条件下呈现出显著的差异性,在评估PNS的益生效应时,需充分考虑其环境背景。
Abstract: Panax notoginseng root saponins (PNS), the main active components of P. notoginseng, interact with the gut microbiota after oral administration. However, the understanding of their interaction under different nutritional conditions remains limited. In this study, human fecal microbiota was anaerobically cultured in vitro using BHI, GAM, and GMM media, with PNS added to the experimental groups (BHIP, GAMP, GMMP). High-performance liquid chromatography was used to quantify the relative metabolic rates of five major saponins under different culture conditions, and 16S rRNA sequencing was performed to analyze changes in microbial community structure. The results showed that the average relative metabolic rates of saponins R1, Rb1 and Rd in the BHIP group exceeded 73%; the GAMP group specifically and efficiently metabolized Rb1, with a metabolic rate above 84%; while the GMMP group only metabolized R1 and Re, with metabolic rates below 25%. Significant differences in microbial community structure were observed among the BHI, GAM, and GMM groups. Compared with their respective control groups, the α-diversity (Shannon index) of the microbiota in the BHIP and GAMP groups was significantly reduced (P < 0.01), and the community structure was significantly reshaped (P < 0.001), whereas no significant changes were observed in the GMMP group. In terms of microbial composition, the BHIP group showed significant enrichment of Lachnoclostridium, Parasutterella, and Bifidobacterium; the GAMP group was significantly enriched with Bifidobacterium and Escherichia-Shigella; and the GMMP group was mainly enriched with Roseburia and Anaerostipes. In conclusion, the interaction between PNS and the gut microbiota varies significantly under different culture conditions, and the environmental context should be fully considered when evaluating the probiotic effects of PNS.
文章引用:段方言, 毛钰婷. 不同培养基条件下三七根总皂苷与人肠道菌群的体外相互作用[J]. 植物学研究, 2026, 15(4): 211-222. https://doi.org/10.12677/br.2026.154025

参考文献

[1] 石礼平, 张国壮, 刘丛盛, 等. 三七化学成分和药理作用研究概况及质量标志物的预测[J]. 中国中药杂志, 2023, 48(8): 2059-2067.
[2] 任恺, 段维勋, 俞波, 等. 中药皂苷成分对高血压大鼠主动脉血管内皮功能相关因子的影响[J]. 西北大学学报(自然科学版), 2018, 48(6): 783-786.
[3] Wang, B., Gao, X., Zhang, Y., Xiao, Y., Chen, T., Shi, Z., et al. (2025) The Role of Panax Notoginseng Saponins in Cerebrovascular Neurological Disorders: An Overview of Mechanisms and Functions. Frontiers in Pharmacology, 16, Article 1693253. [Google Scholar] [CrossRef
[4] 高家乐. 三七总皂苷对缺血性中风后急性期神经保护和恢复期修复的机制研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2024.
[5] Zeng, X., Zhao, J., Nie, Y., Mo, J., Zhou, T. and Jiang, J. (2026) Panax Notoginseng Saponins against Ischemic Stroke: From Molecule to Clinic. Journal of Ethnopharmacology, 356, Article 120834. [Google Scholar] [CrossRef
[6] Lv, N., Wang, L., Zeng, M., Wang, Y., Yu, B., Zeng, W., et al. (2024) Saponins as Therapeutic Candidates for Atherosclerosis. Phytotherapy Research, 38, 1651-1680. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, X., Zhang, B., Zhang, C., Sun, G. and Sun, X. (2021) Effect of Panax Notoginseng Saponins and Major Anti-Obesity Components on Weight Loss. Frontiers in Pharmacology, 11, Article 601751. [Google Scholar] [CrossRef] [PubMed]
[8] 常猛, 陈漪漪, 范亚红, 等. 三七皂苷R1通过激活SLC7A11/GPX4通路抑制铁死亡改善小鼠心肌缺血再灌注损伤后心脏重塑[J]. 中草药, 2026, 57(1): 175-184.
[9] 王汉隆, 孙洋, 刘莎莎, 等. 三七皂苷R1药理作用机制与神经保护作用研究进展[J]. 中国药理学通报, 2024, 40(11): 2020-2025.
[10] Li, M., Huang, Z., Zhang, R. and Zhou, J. (2024) Review of Probiotics, Gut Microorganisms, and Their Enzymes Involved in the Conversion of Ginsenosides. Food Bioscience, 58, Article 103829. [Google Scholar] [CrossRef
[11] Zhang, H., Li, J., Diao, M., Li, J. and Xie, N. (2024) Production and Pharmaceutical Research of Minor Saponins in Panax Notoginseng (Sanqi): Current Status and Future Prospects. Phytochemistry, 223, Article 114099. [Google Scholar] [CrossRef] [PubMed]
[12] Navarro del Hierro, J., Herrera, T., Fornari, T., Reglero, G. and Martin, D. (2018) The Gastrointestinal Behavior of Saponins and Its Significance for Their Bioavailability and Bioactivities. Journal of Functional Foods, 40, 484-497. [Google Scholar] [CrossRef
[13] 王新红, 张迟, 刘琳, 等. 皂苷类成分与肠道菌群相互作用研究进展[J]. 中成药, 2021, 43(7): 1834-1839.
[14] 韩冰, 李静娜, 吕西雨, 等. 肠道菌群代谢转化中药皂苷类成分研究进展[J]. 中草药, 2023, 54(20): 6922-6932.
[15] 袁松竹, 王斌, 周旋, 等. 稀有人参皂苷生物转化的研究进展[J]. 食品工业科技, 2023, 44(12): 480-489.
[16] Wei, W., Li, M., Pan, L., Shao, M., He, X., Li, Y., et al. (2025) Inter-Species and Individualized Biotransformation of Five Saponins by Human Being-and Mouse-Derived Fecal Microbiota. Chinese Medicine, 20, Article No. 132. [Google Scholar] [CrossRef] [PubMed]
[17] Kim, K.A., Jung, I.H., Park, S.H., et al. (2013) Comparative Analysis of the Gut Microbiota in People with Different Levels of Ginsenoside Rb1 Degradation to Compound K. PLOS ONE, 8, e62409. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, M., Wang, Y., Wu, Y., Li, F., Han, M., Dai, Y., et al. (2021) In Vitro Transformation of Protopanaxadiol Saponins in Human Intestinal Flora and Its Effect on Intestinal Flora. Evidence-Based Complementary and Alternative Medicine, 2021, 1-10. [Google Scholar] [CrossRef] [PubMed]
[19] Zhuang, T., Li, W., Yang, L., Wang, Z., Ding, L. and Zhou, M. (2021) Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications. Frontiers in Pharmacology, 12, Article 731288. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, L., Tai, W.C.S. and Hsiao, W.L.W. (2015) Dietary Saponins from Four Popular Herbal Tea Exert Prebiotic-Like Effects on Gut Microbiota in C57BL/6 Mice. Journal of Functional Foods, 17, 892-902. [Google Scholar] [CrossRef
[21] 路婧, 夏雪娟, 黄骏楠, 等. 不同富营养培养基对人肠道菌群的体外培养效果比较分析[J]. 食品与发酵工业, 2024, 50(24): 201-211.
[22] Fu, Y.S., Chen, K.N., Zhang, J.N., et al. (2019) Evaluation of the Effects of Four Media on Human Intestinal Microbiota Culture in Vitro. AMB Express, 9, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[23] Goodman, A.L., Kallstrom, G., Faith, J.J., Reyes, A., Moore, A., Dantas, G., et al. (2011) Extensive Personal Human Gut Microbiota Culture Collections Characterized and Manipulated in Gnotobiotic Mice. Proceedings of the National Academy of Sciences, 108, 6252-6257. [Google Scholar] [CrossRef] [PubMed]
[24] Qu, Z.P., Liu, H.B., Yang, J., et al. (2025) Selective Utilization of Medicinal Polysaccharides by Human Gut Bacteroides and Parabacteroides Species. Nature Communications, 16, Article No. 638. [Google Scholar] [CrossRef] [PubMed]
[25] Dong, W.W., Xuan, F.L., Zhong, F.L., et al. (2017) Comparative Analysis of the Rats’ Gut Microbiota Composition in Animals with Different Ginsenosides Metabolizing Activity. Journal of Agricultural and Food Chemistry, 65, 327-337. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, L., Chen, M., Shao, L., Zhang, W., Li, X. and Huang, W. (2021) Personalized Bioconversion of Panax notoginseng Saponins Mediated by Gut Microbiota between Two Different Diet-Pattern Healthy Subjects. Chinese Medicine, 16, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
[27] Bakkeren, E., Piskovsky, V. and Foster, K.R. (2025) Metabolic Ecology of Microbiomes: Nutrient Competition, Host Benefits, and Community Engineering. Cell Host & Microbe, 33, 790-807. [Google Scholar] [CrossRef] [PubMed]
[28] Shi, H., Newton, D.P., Nguyen, T.H., Estrela, S., Sanchez, J., Tu, M., et al. (2025) Nutrient Competition Predicts Gut Microbiome Restructuring under Drug Perturbations. Cell, 188, 6971-6986.e14. [Google Scholar] [CrossRef
[29] Ma, J., Piao, X., Mahfuz, S., Long, S. and Wang, J. (2022) The Interaction among Gut Microbes, the Intestinal Barrier and Short Chain Fatty Acids. Animal Nutrition, 9, 159-174. [Google Scholar] [CrossRef] [PubMed]
[30] Mukhopadhya, I., Martin, J.C., Shaw, S., Gutierrez-Torrejon, M., Boteva, N., McKinley, A.J., et al. (2025) Novel Insights into Carbohydrate Utilisation, Antimicrobial Resistance, and Sporulation Potential in Roseburia Intestinalis Isolates across Diverse Geographical Locations. Gut Microbes, 17, Article 2473516. [Google Scholar] [CrossRef] [PubMed]
[31] Bocchio, F., Mancabelli, L., Milani, C., Lugli, G.A., Tarracchini, C., Longhi, G., et al. (2025) Compendium of Bifidobacterium-Based Probiotics: Characteristics and Therapeutic Impact on Human Diseases. Microbiome Research Reports, 4, Article 2. [Google Scholar] [CrossRef] [PubMed]
[32] Yang, J., Ren, H., Cao, J., Fu, J., Wang, J., Su, Z., et al. (2025) Gut Commensal Lachnospiraceae Bacteria Contribute to Anti-Colitis Effects of Lactiplantibacillus Plantarum Exopolysaccharides. International Journal of Biological Macromolecules, 309, Article 142815. [Google Scholar] [CrossRef] [PubMed]
[33] Wu, J., Zhao, Y., Wang, X., Kong, L., Johnston, L.J., Lu, L., et al. (2022) Dietary Nutrients Shape Gut Microbes and Intestinal Mucosa via Epigenetic Modifications. Critical Reviews in Food Science and Nutrition, 62, 783-797. [Google Scholar] [CrossRef] [PubMed]
[34] Zheng, F., Zhang, M.Y., Wu, Y.X., et al. (2021) Biotransformation of Ginsenosides (Rb1, Rb2, Rb3, Rc) in Human Intestinal Bacteria and Its Effect on Intestinal Flora. Chemistry & Biodiversity, 18, e2100296.
[35] Shi, M., Fan, H., Liu, H. and Zhang, Y. (2024) Effects of Saponins Rb1 and Re in American Ginseng Intervention on Intestinal Microbiota of Aging Model. Frontiers in Nutrition, 11, Article 1435778. [Google Scholar] [CrossRef] [PubMed]
[36] Chen, H., Shen, J., Li, H., Zheng, X., Kang, D., Xu, Y., et al. (2020) Ginsenoside Rb1 Exerts Neuroprotective Effects through Regulation of Lactobacillus Helveticus Abundance and GABAA Receptor Expression. Journal of Ginseng Research, 44, 86-95. [Google Scholar] [CrossRef] [PubMed]
[37] Zhang, K.X., Zhu, Y., Song, S.X., et al. (2024) Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism. Molecules, 29, Article 1108. [Google Scholar] [CrossRef] [PubMed]